शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSEDESH RAKSHAK AUSHDHALAYA LTD.· Pharmaceuticals & BiotechnologyHighNeutral
Announced Thu, 13 Aug, 2026 · 14:09 IST

Q1 FY27 results show about 36 percent revenue decline YoY

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
—Next day
—
prior close
₹27.00
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.2%—
Pharmaceuticals peers, median of 167sector-0.3%—
Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
+0.0
15m
-1.9
30m
-1.9
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
—+0.2—+0.1—
Next day
—+0.2—-0.3—
2d
—+0.4—-0.2—
3d
—+0.7—-0.3—
4d
—+0.1—-1.5—
5d
—+0.7—-0.9—
1w
—+1.2—-0.6—
15d
—+0.7—+0.3—
1m
—-1.2—-0.1—
2m
—-1.1—-2.3—
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 167Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Desh Rakshak Aushdhalaya, maker of Ayurvedic products, posted Q1 FY27 revenue of Rs 82.83 lakhs versus Rs 129.99 lakhs in Q1 FY26, a fall of around 36 percent. Net profit was Rs 8.03 lakhs versus Rs 9.59 lakhs, down about 16 percent. EPS stood at Rs 0.14. FY26 full year revenue was Rs 711.49 lakhs versus Rs 630.38 lakhs in FY25, with profit at Rs 56.22 lakhs versus Rs 47.66 lakhs. Auditor gave an unmodified limited review opinion.

Likely market impact

Q1 slowdown versus last year may dent short-term sentiment, though full year FY26 held steady. Watch for recovery in coming quarters.